T. Ozaki et al., THE COMPARATIVE EFFECTS OF HALOPERIDOL, (-)-SULPIRIDE, AND SCH23390 ON C-FOS AND C-JUN MESSENGER-RNA EXPRESSIONS, AND AP-1 DNA-BINDING ACTIVITY, European neuropsychopharmacology, 7(3), 1997, pp. 181-187
The c-fos and c-jun mRNA expressions were measured by the RNase protec
tion assay method following intraperitoneal injection of haloperidol,
(D1 and D2 receptor antagonists), (-)-sulpiride, (D2 receptor antagoni
st), and SCH23390, (D1 receptor antagonist). Haloperidol and (-)-sulpi
ride increased their mRNA expressions in a dose-dependent manner, peak
ing at 30 min after injection followed by a gradual decline. The SCH23
390 did not induce expression of either c-fos or c-jun mRNA. A signifi
cant decrease of c-fos as well as C-jun mRNA expression was found due
to pretreatment with SCH23390 (1 mg/kg i.p.) followed by injection of
(-)-sulpiride (20 mg/kg i.p.). The results suggest that the expression
of these mRNAs is closely related to the dopamine D2-like antagonism.
Administration of haloperidol or (-)-sulpiride increased AP-1 DNA bin
ding activity with similar manner of dose-dependence, whereas their ac
tivities were reduced by Fos and Jun antibodies, implying that AP-1 co
mponents, transcriptional factors, forming due to Fos and Jun were act
ually activated by either haloperidol or (-)-sulpiride. (C) 1997 Elsev
ier Science B.V.